Literature DB >> 19604945

Decreased responsiveness to low doses of apomorphine after dopamine agonists and the possible involvement of hyposensitivity of dopamine 'autoreceptors'.

M Baudry1, J Costentin, H Marcais, M P Martres, P Protais, J C Schwartz.   

Abstract

Apomorphine in low dosage (0.3 mg/kg) inhibits climbing behavior, a stereotyped motor activity, in mice. Pretreatment with apomorphine in low doses (0.125 or 0.25 mg/kg) or with piribedil (25 mg/kg), a weak dopamine agonist, results in a less marked inhibitory effect of the test dose of apomorphine. Apomorphine in low dosage or piribedil are also able to antagonize the increase in striatal homovanillic acid elicited by treatment with gammabutyrolactone. Thus, low stimulation of dopamine receptors can regulate the synthesis and release of dopamine even in the absence of impulse flow in dopaminergic neurons, and the initial stimulation of the receptors mediating such effects may lead to a state of hyposensitivity to further stimulation. The hypothesis that such receptors are autoreceptors is discussed.

Entities:  

Year:  1977        PMID: 19604945     DOI: 10.1016/0304-3940(77)90139-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Appearance of a stereotyped apomorphine-induced climbing in unresponsive DBA2 mice after subchronic manipulations of brain dopamine transmission.

Authors:  D Duterte-Boucher; J Costentin
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Response changes after repeated low apomorphine: dopamine autoreceptor desensitization or learning?

Authors:  V J Nickolson; H van Riezen; A M van Delft
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat.

Authors:  J M Monti; M Hawkins; H Jantos; L D'Angelo; M Fernández
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide.

Authors:  R M Post; D C Jimerson; W E Bunney; F K Goodwin
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

5.  The comparative long-term effects of ciladopa (AY-27,110), a chemically novel dopaminergic agonist, in 6-OHDA-lesioned and intact rats.

Authors:  K Voith
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  A gradual score to evaluate the climbing behaviour elicited by apomorphine in mice.

Authors:  H Marcais; P Protais; J Costentin; J C Schwartz
Journal:  Psychopharmacology (Berl)       Date:  1978-03-01       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.